Culture

Crying human tear glands grown in the lab

video: A 4-hour movie of tear gland organoids exposed to noradrenaline.

Image: 
Marie Bannier-Hélaouët, copyright Hubrecht Institute

Researchers from the lab of Hans Clevers (Hubrecht Institute) and the UMC Utrecht used organoid technology to grow miniature human tear glands that actually cry. The organoids serve as a model to study how certain cells in the human tear gland produce tears or fail to do so. Scientists everywhere can use the model to identify new treatment options for patients with tear gland disorders, such as dry eye disease. Hopefully in the future, the organoids can even be transplanted into patients with non-functioning tear glands. The results will be published in Cell Stem Cell on the 16th of March.

The tear gland is located in the upper part of the eye socket. It secretes tear fluid, which is essential for lubrication and nutrition of the cornea and has antibacterial components. Rachel Kalmann (UMCU), ophthalmologist and researcher on the project, explains: "Dysfunction of the tear gland, for example in Sjögren's syndrome, can have serious consequences including dryness of the eye or even ulceration of the cornea. This can, in severe cases, lead to blindness." However, the exact biology behind the functioning of the tear gland was unknown and a reliable model to study it was lacking. That is, until now: researchers from the group of Hans Clevers (Hubrecht Institute) present the first human model to study how the cells in the tear gland cry and what can go wrong.

Crying organoids

The researchers used organoid technology to grow miniature versions of the mouse and human tear gland in a dish. These so-called organoids are tiny 3D-structures that mimic the function of actual organs. After they cultivated these tear gland organoids, the challenge was to get them to cry. Marie Bannier-Hélaouët, researcher on the project, explains: "Organoids are grown using a cocktail of growth-stimulating factors. We had to modify the usual cocktail to make the organoids capable of crying." Once the researchers found the right mixture of growth factors, they could induce the organoids to cry. "Our eyes are always wet, as are the tear glands in a dish," Bannier-Hélaouët says.

Swelling up like a balloon

Similar to the way people cry in response to for example pain, the organoids cry in response to chemical stimuli such as noradrenaline. The cells of the organoids shed their tears on the inside of the organoid, which is called the lumen. As a result, the organoid will swell up like a balloon. The size of the organoids can therefore be used as an indicator of tear production and
-secretion. "Further experiments revealed that different cells in the tear gland make different components of tears. And these cells respond differently to tear-inducing stimuli," says Yorick Post, another researcher on the project.

Atlas of cells

The tear gland is composed of several cell types, but the current model only captures one, the ductal cell. In their paper, the researchers present an atlas of the cells in the tear gland to demonstrate their differences. They generated this atlas using single-cell sequencing; a method with which individual cells can be examined and characterized. Post explains: "In the future, we would like to also grow the other tear gland cell type, so-called acinar cell, in a dish. That way, we can eventually grow a full tear gland in the lab." With the atlas, the researchers were also able to identify new tear products, which help protect the eye from infections.

Transplanting organoids

The development of the miniature tear glands holds promise for patients suffering from tear gland disorders. Scientists everywhere can use the model to identify new drugs for patients who do not produce enough tears. Additionally, the organoids can be used to study how cancers of the tear gland form and may be treated. "And hopefully in the future, this type of organoids may even be transplantable to patients with non-functioning tear glands," Bannier-Hélaouët concludes. The study demonstrates once more the broad potential of organoid technology for science and medicine.

Credit: 
Hubrecht Institute

Brain disease research reveals differences between sexes

image: Human neurodegenerative diseases affect men and women differently, yet sex is rarely included in in vitro bioengineered models of neurodegenerative disease. Sex-related differences include a wide range of biochemical factors, gene expression, and biomechanical cues. These sex differences must be included in blood-brain barrier models to improve the understanding of sex differences in neurodegenerative disease and eventually realize personalized medicine.

Image: 
Callie Weber

WASHINGTON, March 16, 2021 -- Men and women are impacted differently by brain diseases, like Alzheimer's disease and Parkinson's disease. Researchers are urging their colleagues to remember those differences when researching treatments and cures.

In APL Bioengineering, by AIP Publishing, University of Maryland scientists highlight a growing body of research suggesting sex differences play roles in how patients respond to brain diseases, as well as multiple sclerosis, motor neuron disease, and other brain ailments.

That is progress from just a few years ago, said Alisa Morss Clyne, director of the university's Vascular Kinetics Laboratory.

"I have worked with vascular cells for 20 years and, up until maybe about five years ago, if you asked if the sex of my cells mattered at all, I would have said no," Clyne said. Then, she worked on a difficult study in which data appeared "all over the place."

"We separated the cell data by sex, and it all made sense," Clyne said. "It was an awakening for me that we should be studying this."

As of 2020, an estimated 5.8 million Americans were diagnosed with Alzheimer's disease, another 1 million with Parkinson's disease, 914,000 with multiple sclerosis, and 63,000 with motor neuron disease. These diseases happen when nerve cells in the brain and nervous system quit working and, ultimately, die.

The changes are associated with the breakdown of what is called the blood-brain barrier -- a border of cells that keeps the wrong kind of molecules in the bloodstream from entering the brain and damaging it.

Published research has shown differences in the blood-brain barriers of men and women. Some of the research suggests the barrier can be stronger in women than men, and the barriers in men and women are built and behave differently.

That could factor into known differences in the sexes, such as Alzheimer's disease being more prevalent in older women than men, while Parkinson's impacts men more frequently and tends to do so more severely.

The authors said they hope their article will serve as a reminder to researchers not just in their own field, but across the sciences, that accounting for sex differences leads to better results.

"I think there is an awakening in the past 10 years or so that you cannot ignore sex differences," Clyne said. "My goal is to inspire people to include sex differences in their research, no matter what research they are doing."

Credit: 
American Institute of Physics

Nursing home characteristics associated with resident COVID-19 morbidity in communities with high infection rates

What The Study Did: Researchers examined nursing homes in communities with the highest COVID-19 prevalence to identify characteristics associated with resident infection rates.

Authors: Hye-Young Jung, Ph.D., of Weill Cornell Medical College in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.1555)

Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1555?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621

About JAMA Network Open: 

JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Credit: 
JAMA Network

Viruses adapt to 'language of human cells' to hijack protein synthesis

image: Xavier Hernandez, PhD student at the Serrano Lab at the Centre for Genomic Regulation (CRG)

Image: 
Centre for Genomic Regulation (CRG)

The first systematic study of its kind describes how human viruses including SARS-CoV-2 are better adapted to infecting certain types of tissues based on their ability to hijack cellular machinery and protein synthesis.

Carried out by researchers at the Centre for Genomic Regulation (CRG), the findings could help the design of more effective antiviral treatments, gene therapies and vaccines. The study is published today in the journal Cell Reports.

Living organisms make proteins inside their cells. Each protein consists of single units of amino acids which are stitched together according to instructions encoded within DNA. The basic units of these instructions are known as a codons, each of which corresponds to a specific amino acid. A synonymous codon is when two or more codons result in cells producing the same amino acid.

"Different tissues use different languages to make proteins, meaning they preferentially use some synonymous codons over others. We know this because tRNAs, the molecules responsible for recognising codons and sticking on the corresponding amino acid, have different abundances in different tissues," explains Xavier Hernandez, first author of the study and researcher at the CRG.

When a virus infects an organism, it needs to hijack the machinery of the host to produce its own proteins. The researchers set out to investigate whether viruses were specifically adapted to using the synonymous codons used preferentially by the tissues they infect.

The researchers downloaded the publicly available protein sequences of all known human viruses and studied their codon usage. Based on the known tRNA abundances in different tissues, they then determined how well adapted all 502 human-infecting viruses were at infecting 23 different human tissues.

Viral proteins expressed during the early infection stage were better adapted to hijacking the host's protein-making machinery. According to Xavier Hernandez, "well adapted viruses start by using the preferred language of the cell but after taking full control they impose a new one that meets its own needs. This is important because viruses are used in gene therapy to treat genetic diseases and, if we want to correct a mutation in one tissue, we should modify the virus to be optimal for that particular tissue."

The researchers then took a closer look at how different respiratory viruses are adapted to infecting specific tissues based on their codon usage. They studied four different coronaviruses - SARS-CoV, MERS-CoV, SARS-CoV-2, and the bat coronavirus that is most closely related to SARS-CoV-2 - as well as the common flu-causing influenza A virus H1N1.

They found that SARS-CoV-2 adapted its codon usage to lung tissue, the gastrointestinal tract and the brain. As this aligns with known COVID-19 symptoms such as pneumonia, diarrhoea or loss of smell and taste, the researchers hypothesise future treatments and vaccines could take this factor into account to generate immunity in these tissues.

"Out of the respiratory viruses we took a close look at, SARS-CoV-2 is the virus that is most highly adapted to hijacking the protein synthesis machinery of its host tissue, but not more so than influenza or the bat coronavirus. This suggests that factors other than translational efficiency play an important role in infection, for example the ACE2 receptor expression or the immune system," concludes Xavier Hernandez.

The researchers next steps include further developing a biotechnological tool to design optimised protein sequences containing codons adapted to the tissue of interest, which may be useful for the development of gene therapies.

Credit: 
Center for Genomic Regulation

BIDMC researchers model a safe new normal

Boston, Mass. - Just one year after the World Health Organization declared the novel coronavirus a global pandemic, three COVID-19 vaccines are available in the United States, and more than 2 million Americans are receiving shots each day. Americans are eager to get back to business as usual, but experts caution that opening the economy prematurely could allow a potential resurgence of the virus. How foot traffic patterns in restaurants and bars, schools and universities, nail salons and barbershops affect the risk of transmission has been largely unknown.

In an article published in npj Digital Medicine, researcher-physicians from Beth Israel Deaconess Medical Center (BIDMC) used anonymized cell-phone data to build a Business Risk Index, which quantifies the potential risk of COVID-19 transmission in these establishments. The team's index accounts for both the density of visits and the length of time individuals linger inside, providing a more precise description of the human interactions -- and thus risk of viral transmission -- going on inside.

"While business traffic pre-pandemic and during statewide shut downs has been studied, business foot traffic and its relationship to COVID-19 transmission in the so-called 'new normal' of re-opening has not been well understood." said corresponding author Ashley O'Donoghue, PhD, Economist, in the Center for Healthcare Delivery Science at BIDMC. "Many forecasting models use anonymized cell-phone mobility data as a broad measure of the movement of residents. But two regions with same levels of mobility will likely see very different levels of COVID-19 transmission if people in one region are diligently practicing social distancing and people in the other are not."

O'Donoghue and colleagues built their risk index by analyzing trends in foot traffic patterns in more than 1.25 million businesses across eight states from January to June 2020. In the six New England states, New York and California, the team saw a 30 percent drop in high-density foot traffic and long visit lengths to businesses -- two factors that can increase the risk of COVID-19 transmission -- from the pre-pandemic baseline to April 2020. They saw similar declines when they looked at similar risky foot traffic patterns in restaurants, bars, universities and personal care establishments (which includes hair and nail salons and barbershops). In both analyses, the risk index rose steadily starting in mid-June as states eased restrictions.

Next, using county-level COVID-19 data for the same time period, the team demonstrated that their index could accurately forecast future COVID-19 cases with a one-week lag. The team found that an increase in a county's average Business Risk Index was associated with an increase in COVID-19 cases per 10,000 people in one week.

"Not all types of mobility contribute equally to increased risk of transmission, so it is important to directly measure human interaction when weighing the costs and benefits of reopening and lifting restrictions on businesses," said senior author Jennifer P. Stevens, MD, MS, Director of the Center for Healthcare Delivery Science at BIDMC. "Tracking how individuals use different businesses may provide the kind of information policymakers need to re-open different businesses in the safest way possible."

O'Donoghue, Stevens and team are now building an online decision-support tool that will help policymakers and hospital decision-makers monitor weekly risk in their areas. They have also deployed a prototype of their tool for Massachusetts that is being used by a large tertiary academic medical center in Boston to monitor potential surges in their service area, and their index has been integrated as a feature in a forecasting model for a large health system in Massachusetts.

"Our index can better quantify close human interactions, which are important predictors of transmission and help identify potential disease surges," said Stevens.

Credit: 
Beth Israel Deaconess Medical Center

Leprosy drug holds promise as at-home treatment for COVID-19

image: Sumit Chanda, co-senior study author and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys.

Image: 
Sanford Burnham Prebys Medical Discovery Institute

LA JOLLA, CALIF. - March 16, 2021 - A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization's List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammatory response associated with severe COVID-19. Based on these findings, a Phase 2 study evaluating clofazimine as an at-home treatment for COVID-19 could begin immediately.

"Clofazimine is an ideal candidate for a COVID-19 treatment. It is safe, affordable, easy to make, taken as a pill and can be made globally available," says co-senior author Sumit Chanda, Ph.D., professor and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. "We hope to test clofazimine in a Phase 2 clinical trial as soon as possible for people who test positive for COVID-19 but are not hospitalized. Since there is currently no outpatient treatment available for these individuals, clofazimine may help reduce the impact of the disease, which is particularly important now as we see new variants of the virus emerge and against which the current vaccines appear less efficacious."

Promising candidate revealed by screening drug library

Clofazimine was initially identified by screening one of the world's largest collections of known drugs for their ability to block the replication of SARS-CoV-2. Chanda's team previously reported in Nature that clofazimine was one of 21 drugs effective in vitro, or in a lab dish, at concentrations that could most likely be safely achieved in patients.

In this study, the researchers tested clofazimine in hamsters--an animal model for COVID-19--that were infected with SARS-CoV-2. The scientists found that clofazimine lowered the amount of virus in the lungs, including when given to healthy animals prior to infection (prophylactically). The drug also reduced lung damage and prevented "cytokine storm," an overwhelming inflammatory response to SARS-CoV-2 that can be deadly.

"The animals that received clofazimine had less lung damage and lower viral load, especially when receiving the drug before infection," says co-senior author Ren Sun, Ph.D., professor at the University of Hong Kong and distinguished professor emeritus at the University of California, Los Angeles (UCLA). "Besides inhibiting the virus, there are indications that the drug also regulates the host response to the virus, which provides better control of the infection and inflammation."

Clofazimine also worked synergistically with remdesivir, the current standard-of-care treatment for people who are hospitalized due to COVID-19, when given to hamsters infected with SARS-CoV-2. These findings suggest a potential opportunity to stretch the availability of remdesivir, which is costly and in limited supply.

How clofazimine works

The study showed that clofazimine stops SARS-CoV-2 infection in two ways: blocking its entry into cells and disrupting RNA replication (SARS-CoV-2 uses RNA to replicate). Clofazimine was able to reduce the replication of MERS-CoV, the coronavirus that causes Middle East Respiratory Syndrome (MERS), in human lung tissue.

"Potentially most importantly, clofazimine appears to have pan-coronavirus activity, indicating it could be an important weapon against future pandemics," says co-senior author Kwok-Yung Yuen, M.D., chair of Infectious Diseases at the University of Hong Kong, who discovered the coronavirus that causes severe acute respiratory syndrome (SARS). "Our study suggests that we should consider creating a stockpile of ready-made clofazimine that could be deployed immediately if another novel coronavirus emerges."

ADD VIDEO: https://www.youtube.com/watch?v=BEkgvviqaf4&t=136s

In July 2020 Sumit Chanda shared more about his team's race to find a treatment for COVID-19.

Testing clofazimine in the clinic

A Phase 2 trial evaluating clofazimine in combination with interferon beta-1b as a treatment for people with COVID-19 who are hospitalized is ongoing at the University of Hong Kong. Interferon beta-1b is an immunoregulator that is given as an injection and is currently used to treat people with multiple sclerosis.

"Our data suggests that clofazimine should also be tested as a monotherapy for people with COVID-19, which would lower many barriers to treatment," says Chanda. "People with COVID-19 would be able to simply receive a regime of low-cost pills, instead of traveling to a hospital to receive an injection."

Credit: 
Sanford Burnham Prebys

Much of Mars' ancient water was buried in the planet's crust, not lost to space

Several oceans' worth of ancient water may reside in minerals buried below Mars' surface, report researchers. The new study, based on observational data and modeling, shows that much of the red planet's initial water - up to 99% - was lost to irreversible crustal hydration, not escape to space. The findings help resolve the apparent contradictions between predicted atmospheric loss rates, the deuterium to hydrogen ratio (D/H) of present-day Mars and the geological estimates of how much water once covered the Martian surface. Ancient Mars was a wet planet - dry riverbeds and relic shorelines record a time when vast volumes of liquid water flowed across the surface. Today, very little of that water remains, mostly frozen in the planet's ice caps. Previous studies have assumed that the lost water escaped to space over several billion years, an assertion supported by the currently observed atmospheric D/H ratio. However, measurements of the current rate of atmospheric water loss are too low for atmospheric escape alone to explain all Martian water loss. Eva Scheller and colleagues show how large volumes of water could have instead become incorporated into minerals that were buried in the planet's crust. Using observational constraints from orbiting spacecraft, rovers and Martian meteorites, Scheller et al. developed a water budget and D/H model that considers atmospheric escape, volcanic degassing and crustal hydration through chemical weathering. By simulating Martian water loss through geological time and for a range of plausible conditions, the authors discovered that Mars had lost most of its water - between 40-95% - over the Noachian period (~4.1 - 3.7 billion years ago). The results suggest that between 30 and 99% of Mars' initial water was incorporated into minerals and buried in the planet's crust, with subsequent escape to space of the remainder accounting for the currently observed D/H ratio.

Credit: 
American Association for the Advancement of Science (AAAS)

Commercial truck electrification is within reach

When it comes to electric vehicles, particularly for heavy-duty trucks, the limitations of battery technology are often seen as the main barrier to widespread adoption. However, a new analysis concludes that it's the lack of appropriate policies around adoption incentives, charging infrastructure, and electricity pricing that prevents widespread electrification of commercial trucking fleets.

Researchers from the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Los Angeles published a new study that makes the case for prioritizing public policy to help move long-haul trucking from diesel to electric. Doing so will mean huge gains in addressing the climate crisis and avoiding premature deaths due to local vehicular pollution, which disproportionately affects communities of color.

The study analyzes the total cost of ownership of an electric long-haul truck compared to a diesel long-haul truck. Using the current price of a battery pack and assuming a 375-mile range, the researchers found that an electric long-haul truck has a 13% per mile lower total cost of ownership, with a net savings of $200,000 over the lifetime of the electric truck. The total cost of ownership analysis takes into account the purchase price and operating costs over the lifetime of the truck.

The researchers also showed that future reductions in battery costs - taken together with a more aerodynamic design and monetized benefits of reduced pollution - would result in a 50% per mile lower total cost of ownership compared to a diesel long-haul truck by 2030. The electrification of long-haul trucks therefore is possible, and figuring out what is required to move the nation's trucking fleet to widely adopt electric trucks is the next step, the authors said.

"Given the massive economic and environmental benefits, the case for long-haul electric trucking is stronger than ever before," said Berkeley Lab Research Scientist Nikit Abhyankar, one of the authors of the study. "Enabling policies such as adoption and charging infrastructure incentives, sales mandates, and cost-reflective electricity pricing are crucial."

Why focus on long-haul trucks?

Electric cars are becoming more prevalent now, with a substantial increase in global sales and commitments from several major auto manufacturers, including General Motors and Volvo, to sell only electric vehicles by 2030-2035. Long-haul trucks have not experienced the same level of growth, yet they are diesel-fuel guzzlers and a major source of air pollution, contributing more than 20% of U.S. transportation-sector greenhouse gas emissions.

Berkeley Lab scientists have done extensive research tracking the impact of diesel trucks on air quality and public health in disadvantaged communities. Even though diesel trucks account for just a small fraction of motor vehicles, they are responsible for almost one-third of motor vehicle CO2 emissions. The transportation sector was the largest contributor of CO2 emissions associated with the US economy.

"If we can move away from diesel-dependent heavy-duty vehicles, we have a chance at significantly reducing greenhouse gas and particulate emissions from the transportation sector," said Berkeley Lab Staff Scientist Amol Phadke, lead author on this study.

There are currently two main pathways to electrify trucks - fuel cells and batteries - and both are actively being pursued by researchers at Berkeley Lab. Long-haul trucks powered by hydrogen fuel cells are on the horizon, and Berkeley Lab scientists are playing a leading role in a new DOE consortium called the Million Mile Fuel Cell Truck (M2FCT) to advance this technology. Battery-powered electric trucks have seen the most dramatic improvements in technology in recent years, making the battery costs more affordable and competitive.

What's more, electricity from renewable energy sources is becoming more cost-competitive, and Berkeley Lab researchers have shown that decarbonizing the electric grid is feasible in the coming decades, which means electric long-haul trucks would no longer contribute to greenhouse gas emissions.

"It is exciting to see recent dramatic improvements in battery technology and costs," said Phadke. "Electric trucks can generate significant financial savings for truck owners and fleet operators, while enabling inflation-proof freight transportation that can have significant macroeconomic benefits."

Credit: 
DOE/Lawrence Berkeley National Laboratory

Roof-tiles in imperial China: Creating Ximing Temple's lotus-pattern tile ends

image: Basic information about tile ends and imbrices. The figure shows the structure of a tile end and how tile ends and imbrices are used.

Image: 
Kanazawa University

Kanazawa, Japan -- Any visitor to China will have noticed the spectacular roofs on buildings dating from imperial times. However, the question of how these roof tiles were produced has attracted relatively little attention from archaeologists. Now, a team of researchers has conducted a major study of tile ends unearthed at the Ximing Temple in Xi'an, yielding exciting insights into their production.

In a study published in Archaeological Research in Asia, researchers from Kanazawa University and the Chinese Academy of Social Sciences have revealed the significance of minute variations in the tile ends used in the roof of the famous Ximing Temple in Xi'an, built during the Tang dynasty (618-907 AD) when Xi'an (then known as Chang'an) was the imperial capital.

The researchers conducted an investigation of 449 tile ends with lotus patterns from various periods during the Tang dynasty that had been recovered from the Ximing Temple. "We were interested in the variations in the tile ends, both those within the conscious control of the artisans who made the tiles, such as whether to use simple or complex lotus patterns, and those outside their control, such as the marks left by the deterioration of the molds used to make the tiles," says lead author of the study Meng Lyu.

"We discovered that the degree of minor variation in the tile ends increases significantly in the later samples," adds author Guoqiang Gong. "This suggests to us that there was a shift away from the centralized manufacturing of imperial building materials during the Early Tang period toward one in which small private artisans played an important role in the Late Tang period."

Intriguingly, the study has revealed traces of the coming together of two distinct cultural traditions. "We found that there were, in fact, two separate production systems at work to make the title ends," notes author Chunlin Li. "One produced tile ends with compound petal patterns and curved incisions, whereas the other made end tiles with simple petal patterns and scratched incisions." These two styles may ultimately have their origins during an earlier historical period when the Northern Wei dynasty was divided into two regimes on either side of the Taihang mountain range.

This study demonstrates that studying the roof tiles of China's grand imperial buildings can reveal a great deal about the circumstances of their production and yield insights into larger historical questions.

Credit: 
Kanazawa University

The bald truth - altered cell divisions cause hair thinning

image: Young HFSCs undergo symmetric cell divisions (SCDs) and asymmetric cell divisions (ACDs) to generate new bulge cells for their self-renewal and expansion. Whereas aged HFSCs provoke hemidesmosomal instability including COL17A1 and undergo stress response (SR) type ACDs to induce epidermal differentiation that triggers their delamination, thereby causing stepwise miniaturization of HFs and hair thinning and loss.

Image: 
Department of Stem Cell Biology,TMDU

Researchers from Tokyo Medical and Dental University (TMDU) identify a novel mechanism underlying hair thinning and loss during aging

Tokyo, Japan - Hair grows from stem cells residing in hair follicles. During aging, the capability of hair follicles to grow hair is successively lost, leading to hair thinning and ultimately hair loss. In a new study, researchers from Tokyo Medical and Dental University (TMDU) and the University of Tokyo identified a novel mechanism by which hair follicles lose their regenerative capabilities.

Hair follicles are mini-organs from which new hair constantly grows. The basis for new hair growth is the proper function of hair follicle stem cells (HFSCs). HFSCs undergo cyclic symmetric and asymmetric cell divisions (SCDs and ACDs). SCDs generate two identical cells that go on to have the same fate, while ACDs generate a differentiating cell and a self-renewing stem cell. The combination ensures that the stem cell population continues to exist, yet how those contribute to the loss of HFSC function due to aging is not yet completely understood.

"For proper tissue function, symmetric and asymmetric cell divisions have to be in balance," says corresponding author of the study Emi Nishimura. "Once stem cells preferentially undergo one of either or, worse yet, deviate from the typical process of either type of cell division, the organ suffers. In this study, we wanted to understand how stem cell division plays into hair grows during aging."

To achieve their goal, the researchers investigated stem cell division in HFSCs in young and aged mice by employing two different types of assays: Cell fate tracing and cell division axis analyses. In the former, HFSCs were marked with a fluorescent protein so they could be followed over time, while in the latter the angle of HFSC division was measured. Strikingly, the researchers were able to show that while HFSCs in young mice underwent typical symmetric and asymmetric cell divisions to regenerate hair follicles, during aging they adopted an atypical senescent type of asymmetric cell division.

But why does the mode of cell division change so drastically during aging? To answer this question, the researchers focused on hemidesmosomes, a class of protein that connect the cells to the extracellular matrix (ECM; proteins surrounding cells). Cell-ECM have long been known to confer polarity to cells, i.e., that the cells can sense their localization within a given space through the action of specific proteins. The researchers found that during aging both hemidesmosomal and cell polarity proteins become destabilized, resulting in the generation of aberrantly differentiating cells during division of HFSCs. As a result, HFSCs become exhausted and lost (leading to hair thinning and hair loss) over time.

"These are striking results that show how hair follicles lose their ability to regenerate hair over time," says first author of the study Hiroyuki Matsumura. "Our results may contribute to the development of new approaches to regulate organ aging and aging-associated diseases."

Credit: 
Tokyo Medical and Dental University

HKUST researchers unlock the micro-molecular physiochemical mechanism of dental plaque formation

image: (Left up panel) Effect of biosynthetic gene cluster muf or mutanofactin-697 (5) on biofilm formation on the surface of artificial acryl teeth. (Left bottom panel) Proposed biosynthetic pathway for mutanofactin-697 (5). (Right panel) Proposed mechanism for mutanofactin-697 (5)-promoted biofilm formation of streptococci. After being biosynthesized and secreted from a producing streptococcus, 5 binds to self and neighboring streptococci, forming surface layers around bacterial cells. The hydrophobic layer increases bacterial cell surface hydrophobicity, promotes initial bacterial adhesion and subsequent biofilm formation and maturation. In addition, 5 also directly binds to eDNA and facilities eDNA-mediated cell aggregation and biofilm formation.

Image: 
HKUST

An inter-disciplinary team of researchers led by Prof. Qian Peiyuan, Chair Professor at the Hong Kong University of Science and Technology (HKUST)'s Department of Ocean Science and Division of Life Science has unraveled how a novel microbial small molecule released by Streptococcus mutans (S. mutans) - a bacterium commonly found in the human oral cavity - is connected to dental caries development using a synthetic biology approach, offering new insights to the health impact of the human oral microbiota and facilitating future research on the prevention of tooth decay. The research findings were recently published in the prestigious scientific journal Nature Chemical Biology and reported by Nature as one of the research highlights.

Every wetted surface on our planet is covered by biofilm made of microbial cells meshed in extracellular organic matrix. An early study by the National Institutes of Health (NIH) concluded that over 80% of human bacterial infection were caused by biofilm . Thus, S. mutans, a natural and primary inhabitant of the human oral cavity that has strong ability to form biofilms and produce organic acids, has long been acknowledged as the major etiological agent of dental caries.

The development of dental caries, or tooth decay, is a complex process that mainly depends on the presence of microbial biofilms on the tooth surfaces, which are known as dental plaque. Tooth decay has been recognized as one of the most common bacterial infections and costly chronic conditions afflicting humans. Annually, the global economic burden of treating tooth decay amounts to billions of dollars(1) . Although the macromolecular agents of S. mutans for biofilm formation and development have been extensively investigated, the role of small-molecule secondary metabolites in biofilm formation of S. mutans remains largely unexplored.

Prof. Qian's research team has been studying the microbe-animal interactions mediated by signal molecules from biofilm, using integrated genomics, transcriptomics and chemical biology approaches. Recently, the research team has extended their work on biofilms related to public health.

In collaboration with Prof. ZHANG Wen-Jun and Prof. Roya MABOUDIAN at University of California at Berkeley, and Prof. Robert BURNE at College of Dentistry, University of Florida, the team has discovered a polyketide/non-ribosomal peptide biosynthetic gene cluster, muf, which directly correlates with a strong biofilm-forming capability, from S. mutans strains clinically isolated from dental plaque. Then, the muf-associated bioactive product, mutanofactin-697 that contains a novel molecular scaffold was identified. Further mode-of-action studies revealed that this unique microbial secondary metabolite promotes biofilm formation via an unprecedented physicochemical mechanism: this small molecule binds to S. mutans cells and extracellular DNA, increases bacterial hydrophobicity, and subsequently promotes bacterial adhesion and biofilm formation.

Prof. Qian, also David von Hansemann Professor of Science at HKUST, said, "Our findings provide the first example of a microbial secondary metabolite promoting biofilm formation via a physicochemical approach, highlighting the significance of secondary metabolism in mediating critical processes related to the development of dental caries."

LI Zhongrui, a researcher of the team, said this discovery will enable further mechanistic exploration of mutanofactin-related chemical regulatory processes in human oral ecology and streptococci-induced dental caries incidence and prevention.

Credit: 
Hong Kong University of Science and Technology

Consumption of added sugar doubles fat production

Sugar is added to many common foodstuffs, and people in Switzerland consume more than 100 grams of it every day. The high calorie content of sugar causes excessive weight and obesity, and the associated diseases. But does too much sugar have any other harmful effects if consumed regularly? And if so, which sugars in particular?

Even moderate amounts of sugar increase fat synthesis

Researchers at the University of Zurich (UZH) and the University Hospital Zurich (USZ) have been investigating these questions. Compared to previous studies, which mainly examined the consumption of very high amounts of sugar, their results show that even moderate amounts lead to a change in the metabolism of test participants. "Eighty grams of sugar daily, which is equivalent to about 0,8 liters of a normal soft drink, boosts fat production in the liver. And the overactive fat production continues for a longer period of time, even if no more sugar is consumed," says study leader Philipp Gerber of the Department of Endocrinology, Diabetology and Clinical Nutrition.

Ninety-four healthy young men took part in the study. Every day for a period of seven weeks, they consumed a drink sweetened with different types of sugar, while the control group did not. The drinks contained either fructose, glucose or sucrose (table sugar which is a combination of fructose and glucose). The researchers then used tracers (labeled substances that can be traced as they move through the body) to analyze the effect of the sugary drinks on the lipid metabolism.

Fructose and sucrose double fat production beyond food intake

Overall, the participants did not consume more calories than before the study, as the sugary drink increased satiety and they therefore reduced their calorie intake from other sources. Nevertheless, the researchers observed that fructose has a negative effect: "The body's own fat production in the liver was twice as high in the fructose group as in the glucose group or the control group - and this was still the case more than twelve hours after the last meal or sugar consumption," says Gerber. Particularly surprising was that the sugar we most commonly consume, sucrose, boosted fat synthesis slightly more than the same amount of fructose. Until now, it was thought that fructose was most likely to cause such changes.

Development of fatty liver or diabetes more likely

Increased fat production in the liver is a significant first step in the development of common diseases such as fatty liver and type-2 diabetes. From a health perspective, the World Health Organization recommends limiting daily sugar consumption to around 50 grams or, even better, 25 grams. "But we are far off that mark in Switzerland," says Philipp Gerber. "Our results are a critical step in researching the harmful effects of added sugars and will be very significant for future dietary recommendations."

Credit: 
University of Zurich

A new way to measure human wellbeing towards sustainability

From science to implementation: How do we know if humankind is moving in the right direction towards global sustainability? The ambitious aim of the SDGs is a global call to action to end poverty, protect the planet, and ensure all people enjoy peace and prosperity by 2030. To monitor progress towards these goals, a set of over 220 indicators is used, but there is a danger that one can no longer see the forest for the trees. A single comprehensive indicator to assess the overall progress is needed. In a new paper published in the Proceedings of the National Academy of Sciences (PNAS), IIASA researchers and colleagues from the University of Vienna, the Vienna Institute of Demography (Austrian Academy of Sciences), and the Bocconi University present a bespoke indicator based on life expectancy and benchmarks of objective and subjective wellbeing: The Years of Good Life (YoGL) indicator.

"Many existing indicators of wellbeing do not consider the basic fact that being alive is a prerequisite for enjoying any quality of life. In addition, they often disregard the length of a life. Life expectancy has long been used as a very comprehensive indicator of human development, with avoiding premature death being a universally shared aspiration. However, mere survival is not enough to enjoy life and its qualities," explains lead author Wolfgang Lutz, Founding Director of the Wittgenstein Centre for Demography and Global Human Capital, a collaborative center of the Austrian Academy of Sciences (Vienna Institute of Demography), International Institute for Applied Systems Analysis, and University of Vienna. "The Years of Good Life indicator only counts a year as a good year if individuals are simultaneously not living in absolute poverty, free from cognitive and physical limitations, and report to be generally satisfied with their lives."

The results show that YoGL differs substantially between countries. While in most developed countries, 20-year-old women can expect to have more than 50 years of good life left (with a record of 58 years in Sweden), women in the least developed countries can expect less than 15 years (with a record low of 10 years for women in Yemen). While life expectancy is higher for women than for men in every country, female Years of Good Life are lower than those of males in most developing countries. This reveals a significant gender inequality in objective living conditions and subjective life satisfaction in most of these countries.

The paper - funded by an Advanced Grant to Lutz from the European Research Council - presents a first step in the great challenge to comprehensively assess sustainable human wellbeing that also considers feedbacks from environmental change. Unlike many other indicators, YoGL is not restricted to the national level but can be assessed for flexibly defined sub-populations and over long-time horizons because it has substantive meaning in its absolute value. It also has the potential to become a broadly used "currency" for measuring the benefits of certain actions, complementing assessments based on purely monetary units. For example, the social costs of carbon could potentially be evaluated in terms of Years of Good Life lost among future generations, rather than only in dollar terms - making it a key indicator to measure sustainable progress in an integrated and tangible way. Applying the same logic to the recent COVID-19 pandemic, study coauthor Erich Striessnig adds that YoGL also represents a major improvement over conventional indicators in assessing the long-term success of intervention measures.

"If we used YoGL as a currency to measure the long-term impacts of the ongoing crisis rather than GDP per capita or life expectancy, we would not only account for the material losses and the lost life years, but also for the losses in physical and cognitive wellbeing, as well as for the losses incurred by the younger generations in terms of their human capital resulting from school closures. Lack of consistent data that is needed to calculate YoGL does of course remain an issue. Political decision makers should, however, aim for improved data availability to make better informed decisions based on indicators such as YoGL," Striessnig concludes.

Credit: 
International Institute for Applied Systems Analysis

Deforestation taking a heavy toll on international bird haven

image: Fork-tailed woodnymph

Image: 
Pablo Negret

An analysis has found deforestation is severely affecting forest bird species in Colombia, home to the greatest number of bird species in the world.

University of Queensland-led research, steered by Dr Pablo Negret, analysed the impact of deforestation on 550 bird species, including 69 only found in the South American nation.

"Our study has shown an astonishing reduction in bird species habitat," Dr Negret said.

"One third of the forest bird species in Colombia have lost at least a third of their historical habitat, and that's just using the most recent data we have available - from 2015.

"Moreover, 18 per cent or 99 species have lost more than half of their historical habitat to date.

"By 2040, we expect this will increase to 38 per cent or 209 species.

"Sadly, many of those species are endemic to the country and are not currently classified as threatened by the International Union for Conservation of Nature, suggesting that there are many unlisted species that face an imminent extinction threat from ongoing habitat loss."

Dr Negret said the results were concerning but not surprising.

"Deforestation is one of the main drivers of habitat loss for many species in the tropics," he said.

"We know that deforestation affects thousands of species in these ecosystems, but our attention is usually focused on a tiny fraction - threatened and charismatic species.

"This study provides more data on species previously thought abundant that are actually dwindling - hopefully we can shine a light on them, so they can be recognised as under threat and don't fall through the cracks."

The researchers used historical and present satellite forest cover data, while collating spatial information on other variables associated with deforestation patterns.

UQ's Professor Martine Maron said the research would help predict future habitat loss for already-threatened species.

"This methodology, and the technologies behind it, allow us to identify places where future habitat loss is predicted.

"This means that we can reveal the locations where threatened species are most likely to lose precious habitat, and prioritise their protection.

"And, in a country with growing threats to rich bird diversity, it pays to be ahead of the game."

The authors hope the Colombian government and NGOs working in this space will use the research to guide conservation of Colombia's bird species.

Credit: 
University of Queensland

Flat brain organoids grown on 3D-printed scaffolds show intrinsic gyrification

The research, by an international team from the Autonomous University of Madrid and the Technical University of Denmark, used 3D printing to create scaffolds for engineered flat brain organoids. The scaffolds allowed the brain organoid size to be significantly increased and after 20 days, self-generated folding was observed. Their results are published in the IOP Publishing journal Biofabrication.

The work aims to address several of the shortcomings of existing brain organoids. One of the lead authors, Theresa Rothenbücher, said: "The lack of vascularization leads to diffusion limitations for nutrients and oxygen, resulting in a necrotic tissue core for organoids larger than approximately 500 μm. In an attempt to solve this problem, brain organoids have been vascularized. While including endothelial cells in the culture system increases the complexity of the model, the generated vessel structures show no functionality (blood flow) in vitro. We are able to circumvent this issue by applying bioengineering techniques."

Another lead author, Hakan Gürbüz, commented: "By culturing brain organoids with a polycaprolactone (PCL) scaffold, we were able to modify their shape into a flat morphology. Engineered Flat Brain Organoids (efBOs) possess advantageous diffusion conditions and thus their tissue is better supplied with oxygen and nutrients, preventing the formation of a necrotic tissue core. The shift from a spherical to a flat shape leads to a significant increase in size and surface-to-volume ratio of the brain organoids." eFBOs also offer increased potential to create biologically relevant systems, due to the complexity of the models that they enable. Ensuring the long-term viability of these models is a major aim of this branch of research, which has been difficult until now; flat organoids address the problem of longevity by avoiding the formation of necrotic tissue.

"The 3D printing of scaffolds was key to overcoming the shape limitations of the previous spherical models. Contributing author Jenny Emneus says, 3D printing enables: "Reproducible fabrication of specific 3D scaffolds with high architectural complexity, precision and design versatility. By introducing a 3D-printed scaffold into the culture protocol, the size of the brain organoids and the tissue density and thickness can be tuned."

The resulting model showed consistent formation of neuroepithelial folding resembling gyrification. Contributing author Alberto Martinez-Serrano said: "...we were able to observe folding reminiscent of gyrification around day 20, which was self-generated by the tissue. To our knowledge, this is the first study that reports intrinsically caused gyrification of neuronal tissue in vitro." The appearance of gyrification reflects a further increase of the surface area and resembles the process of human brain development.

Although brain organoids do not reproduce the exact anatomy of a human brain, they are an important step towards recapitulating the human brain; tissue-equivalent models such as these organoids can replace the use of animal models in research into drug screening for toxicity and the understanding of disease progression. Alberto Martinez-Serrano continued: "The human brain is the most complex organ of the body and due to its inaccessibility, we still lack scientific knowledge about brain development and diseases. Studies with animals are ethically restricted and should be minimized. Especially for drug screening applications, a highly reproducible protocol with simple tissue culture steps and consistent output, is required. We consider our efBO protocol as a next step towards the generation of a stable and reliable human brain model for drug screening applications and spatial patterning experiments."

Credit: 
IOP Publishing